Ongoing studies are evaluating inexpensive screening methods that can be implemented and sustained in low-resource settings, based on the detection of antitumor antigens by immunoglobulin M (IgM) Abs in the serum of female mice with BC. Here, CD40LG is linked to breast cancer.